Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | ID3 |
Upstream (Parents) |
---|
(<<) OLFML3 → ID3 |
(<<) ID4 → ID3 |
(<<) ID1 → ID3 |
(<<) SNAI2 → ID3 |
(<<) RBMS1 → ID3 |
(<<) CXCR7 → ID3 |
(<<) TMEM204 → ID3 |
Downstream (Children) |
---|
ID3 → FGF20 (>>) |
ID3 → SVEP1 (>>) |
ID3 → STATH (>>) |
ID3 → GSC2 (>>) |
ID3 → MAK (>>) |
ID3 → BEST2 (>>) |
ID3 → LAMA1 (>>) |
ID3 → ATP10A (>>) |
ID3 → ID1 (>>) |
ID3 → DYNC1I1 (>>) |
ID3 → TSGA14 (>>) |
ID3 → RBMS1 (>>) |
ID3 → DCAF15 (>>) |